Evaluation of expanded 2-aminobenzothiazole library as inhibitors of a model histidine kinase and virulence suppressors in Pseudomonas aeruginosa
- PMID: 39362083
- PMCID: PMC11614690
- DOI: 10.1016/j.bioorg.2024.107840
Evaluation of expanded 2-aminobenzothiazole library as inhibitors of a model histidine kinase and virulence suppressors in Pseudomonas aeruginosa
Abstract
Bacterial resistance to antibiotics is a rapidly increasing threat to human health. New strategies to combat resistant organisms are desperately needed. One potential avenue is targeting two-component systems, which are the main bacterial signal transduction pathways used to regulate development, metabolism, virulence, and antibiotic resistance. These systems consist of a homodimeric membrane-bound sensor histidine kinase, and a cognate effector, the response regulator. Histidine kinases play an essential role in the regulation of multiple virulence mechanisms including toxin production, immune evasion, and antibiotic resistance. Targeting virulence, as opposed to development of bactericidal compounds, could reduce evolutionary pressure for acquired resistance. Additionally, compounds targeting the highly conserved catalytic and adenosine triphosphate-binding (CA) domain have the potential to impair multiple two-component systems that regulate virulence in one or more pathogens. We conducted in vitro structure-activity relationship studies of 2-aminobenzothiazole-based inhibitors designed to target the CA domain. We found that these compounds, which inhibit the model histidine kinase, HK853 from Thermotoga maritima, have anti-virulence activities inPseudomonas aeruginosa, reducing motility phenotypes and toxin production associated with the pathogenic functions of this bacterium.
Keywords: Bacteria; Histidine Kinase; Pseudomonas aeruginosa; Two-Component System; Virulence.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Erin Carlson reports financial support and equipment, drugs, or supplies were provided by University of Minnesota Twin Cities. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Update of
-
Evaluation of Expanded 2-Aminobenzothiazole Library for Inhibition of Pseudomonas aeruginosa Virulence Phenotypes.bioRxiv [Preprint]. 2024 Jan 10:2023.05.02.539119. doi: 10.1101/2023.05.02.539119. bioRxiv. 2024. Update in: Bioorg Chem. 2024 Dec;153:107840. doi: 10.1016/j.bioorg.2024.107840. PMID: 37205454 Free PMC article. Updated. Preprint.
References
-
- World Health Organization: Antimicrobial resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance (accessed May 17th, 2022).
-
- Boluarte T; Schulze U The Case for a Subscription Model to Tackle Antimicrobial Resistance; Boston Consulting Group: Boston Consulting Group, February 11th, 2022.
-
- Lai CK; Ng RW; Leung SS; Hui M; Margaret I, Overcoming the rising incidence and evolving mechanisms of antibiotic resistance by novel drug delivery approaches - An overview. Adv. Drug Deliv. Rev. 2022, 181. - PubMed
-
- Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H, Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms. Chem. Biol. Drug Des. 2015, 86 (4), 379–99. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
